<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2007-09-11" modified="2017-10-25" version="144">
<accession>Q92835</accession>
<accession>O00145</accession>
<accession>Q13544</accession>
<accession>Q13545</accession>
<accession>Q6P5A4</accession>
<accession>Q92656</accession>
<accession>Q9UE80</accession>
<name>SHIP1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1</fullName>
<ecNumber>3.1.3.86</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Inositol polyphosphate-5-phosphatase of 145 kDa</fullName>
<shortName>SIP-145</shortName>
</alternativeName>
<alternativeName>
<fullName>SH2 domain-containing inositol 5'-phosphatase 1</fullName>
<shortName>SH2 domain-containing inositol phosphatase 1</shortName>
<shortName>SHIP-1</shortName>
</alternativeName>
<alternativeName>
<fullName>p150Ship</fullName>
<shortName>hp51CN</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">INPP5D</name>
<name type="synonym">SHIP</name>
<name type="synonym">SHIP1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Biochem. Biophys. Res. Commun." volume="225" first="243" last="249">
<title>Cloning and expression of a human placenta inositol 1,3,4,5-tetrakisphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase.</title>
<authorList>
<person name="Drayer A.L."/>
<person name="Pesesse X."/>
<person name="De Smedt F."/>
<person name="Woscholski R."/>
<person name="Parker P."/>
<person name="Erneux C."/>
</authorList>
<dbReference type="PubMed" id="8769125"/>
<dbReference type="DOI" id="10.1006/bbrc.1996.1161"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>ENZYME ACTIVITY</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT TYR-1169</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="Blood" volume="88" first="2833" last="2840">
<title>Cloning and characterization of human SHIP, the 145-kD inositol 5-phosphatase that associates with SHC after cytokine stimulation.</title>
<authorList>
<person name="Ware M.D."/>
<person name="Rosten P."/>
<person name="Damen J.E."/>
<person name="Liu L."/>
<person name="Humphries R.K."/>
<person name="Krystal G."/>
</authorList>
<dbReference type="PubMed" id="8874179"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH SHC1</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="Curr. Biol." volume="6" first="438" last="445">
<title>Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2.</title>
<authorList>
<person name="Kavanaugh W.M."/>
<person name="Pot D.A."/>
<person name="Chin S.M."/>
<person name="Deuter-Reinhard M."/>
<person name="Jefferson A.B."/>
<person name="Norris F.A."/>
<person name="Masiarz F.R."/>
<person name="Cousens L.S."/>
<person name="Majerus P.W."/>
<person name="Williams L.T."/>
</authorList>
<dbReference type="PubMed" id="8723348"/>
<dbReference type="DOI" id="10.1016/S0960-9822(02)00511-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-1139 (ISOFORM 1)</scope>
<scope>ENZYME ACTIVITY</scope>
<scope>INTERACTION WITH GRB2</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1997" name="Blood" volume="89" first="1876" last="1885">
<title>The human SHIP gene is differentially expressed in cell lineages of the bone marrow and blood.</title>
<authorList>
<person name="Geier S.J."/>
<person name="Algate P.A."/>
<person name="Carlberg K."/>
<person name="Flowers D."/>
<person name="Friedman C."/>
<person name="Trask B."/>
<person name="Rohrschneider L.R."/>
</authorList>
<dbReference type="PubMed" id="9058707"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1997" name="Blood" volume="89" first="2745" last="2756">
<title>Purification and molecular cloning of SH2- and SH3-containing inositol polyphosphate-5-phosphatase, which is involved in the signaling pathway of granulocyte-macrophage colony-stimulating factor, erythropoietin, and Bcr-Abl.</title>
<authorList>
<person name="Odai H."/>
<person name="Sasaki K."/>
<person name="Iwamatsu A."/>
<person name="Nakamoto T."/>
<person name="Ueno H."/>
<person name="Yamagata T."/>
<person name="Mitani K."/>
<person name="Yazaki Y."/>
<person name="Hirai H."/>
</authorList>
<dbReference type="PubMed" id="9108392"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH GRB2</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>VARIANT TYR-1169</scope>
<source>
<tissue>B-cell</tissue>
<tissue>Lymph</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1999" name="J. Immunol." volume="162" first="5719" last="5727">
<title>CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis.</title>
<authorList>
<person name="Mikhalap S.V."/>
<person name="Shlapatska L.M."/>
<person name="Berdova A.G."/>
<person name="Law C.L."/>
<person name="Clark E.A."/>
<person name="Sidorenko S.P."/>
</authorList>
<dbReference type="PubMed" id="10229804"/>
</citation>
<scope>INTERACTION WITH SLAMF1</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="Cell. Signal." volume="12" first="317" last="326">
<title>The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the dok1 phosphoprotein in bcr-Abl transformed cells.</title>
<authorList>
<person name="Dunant N.M."/>
<person name="Wisniewski D."/>
<person name="Strife A."/>
<person name="Clarkson B."/>
<person name="Resh M.D."/>
</authorList>
<dbReference type="PubMed" id="10822173"/>
<dbReference type="DOI" id="10.1016/S0898-6568(00)00073-5"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH DOK1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2002" name="J. Immunol." volume="169" first="5441" last="5450">
<title>Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.</title>
<authorList>
<person name="Freeburn R.W."/>
<person name="Wright K.L."/>
<person name="Burgess S.J."/>
<person name="Astoul E."/>
<person name="Cantrell D.A."/>
<person name="Ward S.G."/>
</authorList>
<dbReference type="PubMed" id="12421919"/>
<dbReference type="DOI" id="10.4049/jimmunol.169.10.5441"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
<title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
<authorList>
<person name="Rush J."/>
<person name="Moritz A."/>
<person name="Lee K.A."/>
<person name="Guo A."/>
<person name="Goss V.L."/>
<person name="Spek E.J."/>
<person name="Zhang H."/>
<person name="Zha X.-M."/>
<person name="Polakiewicz R.D."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="15592455"/>
<dbReference type="DOI" id="10.1038/nbt1046"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-915</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2006" name="Cell. Signal." volume="18" first="2022" last="2032">
<title>The Src homology 2-containing inositol 5-phosphatase 1 (SHIP1) is involved in CD32a signaling in human neutrophils.</title>
<authorList>
<person name="Vaillancourt M."/>
<person name="Levasseur S."/>
<person name="Tremblay M.-L."/>
<person name="Marois L."/>
<person name="Rollet-Labelle E."/>
<person name="Naccache P.H."/>
</authorList>
<dbReference type="PubMed" id="16682172"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2006.03.012"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="J. Immunol." volume="183" first="5502" last="5510">
<title>FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling.</title>
<authorList>
<person name="Kochi Y."/>
<person name="Myouzen K."/>
<person name="Yamada R."/>
<person name="Suzuki A."/>
<person name="Kurosaki T."/>
<person name="Nakamura Y."/>
<person name="Yamamoto K."/>
</authorList>
<dbReference type="PubMed" id="19843936"/>
<dbReference type="DOI" id="10.4049/jimmunol.0901982"/>
</citation>
<scope>INTERACTION WITH FCRL3</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2011" name="Immunol. Lett." volume="134" first="174" last="182">
<title>FCRL6 receptor: expression and associated proteins.</title>
<authorList>
<person name="Kulemzin S.V."/>
<person name="Zamoshnikova A.Y."/>
<person name="Yurchenko M.Y."/>
<person name="Vitak N.Y."/>
<person name="Najakshin A.M."/>
<person name="Fayngerts S.A."/>
<person name="Chikaev N.A."/>
<person name="Reshetnikova E.S."/>
<person name="Kashirina N.M."/>
<person name="Peclo M.M."/>
<person name="Rutkevich P.N."/>
<person name="Shevelev A.Y."/>
<person name="Yanushevskaya E.V."/>
<person name="Baranov K.O."/>
<person name="Mamonkin M."/>
<person name="Vlasik T.N."/>
<person name="Sidorenko S.P."/>
<person name="Taranin A.V."/>
<person name="Mechetina L.V."/>
</authorList>
<dbReference type="PubMed" id="20933011"/>
<dbReference type="DOI" id="10.1016/j.imlet.2010.09.023"/>
</citation>
<scope>INTERACTION WITH FCRL6</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-960; THR-963 AND SER-971</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="16">
<citation type="submission" date="2008-04" db="PDB data bank">
<title>Solution structure of the human SHIP SH2 domain.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 1-112</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2003" name="Leukemia" volume="17" first="1" last="8">
<title>Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia.</title>
<authorList>
<person name="Luo J.-M."/>
<person name="Yoshida H."/>
<person name="Komura S."/>
<person name="Ohishi N."/>
<person name="Pan L."/>
<person name="Shigeno K."/>
<person name="Hanamura I."/>
<person name="Miura K."/>
<person name="Iida S."/>
<person name="Ueda R."/>
<person name="Naoe T."/>
<person name="Akao Y."/>
<person name="Ohno R."/>
<person name="Ohnishi K."/>
</authorList>
<dbReference type="PubMed" id="12529653"/>
<dbReference type="DOI" id="10.1038/sj.leu.2402725"/>
</citation>
<scope>VARIANT GLU-685</scope>
</reference>
<comment type="function">
<text evidence="9 12">Phosphatidylinositol (PtdIns) phosphatase that specifically hydrolyzes the 5-phosphate of phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3) to produce PtdIns(3,4)P2, thereby negatively regulating the PI3K (phosphoinositide 3-kinase) pathways. Acts as a negative regulator of B-cell antigen receptor signaling. Mediates signaling from the FC-gamma-RIIB receptor (FCGR2B), playing a central role in terminating signal transduction from activating immune/hematopoietic cell receptor systems. Acts as a negative regulator of myeloid cell proliferation/survival and chemotaxis, mast cell degranulation, immune cells homeostasis, integrin alpha-IIb/beta-3 signaling in platelets and JNK signaling in B-cells. Regulates proliferation of osteoclast precursors, macrophage programming, phagocytosis and activation and is required for endotoxin tolerance. Involved in the control of cell-cell junctions, CD32a signaling in neutrophils and modulation of EGF-induced phospholipase C activity. Key regulator of neutrophil migration, by governing the formation of the leading edge and polarization required for chemotaxis. Modulates FCGR3/CD16-mediated cytotoxicity in NK cells. Mediates the activin/TGF-beta-induced apoptosis through its Smad-dependent expression. May also hydrolyze PtdIns(1,3,4,5)P4, and could thus affect the levels of the higher inositol polyphosphates like InsP6.</text>
</comment>
<comment type="catalytic activity">
<text evidence="15 16">1-phosphatidyl-1D-myo-inositol 3,4,5-triphosphate + H(2)O = 1-phosphatidyl-1D-myo-inositol 3,4-diphosphate + phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="4">Activated upon translocation to the sites of synthesis of PtdIns(3,4,5)P3 in the membrane.</text>
</comment>
<comment type="subunit">
<text evidence="5 6 13 14">Interacts with tyrosine phosphorylated form of SHC1 (PubMed:8874179). Interacts with tyrosine phosphorylated form of DOK1 (PubMed:10822173). Interacts with tyrosine phosphorylated form of DOK3 (By similarity). Interacts with tyrosine phosphorylated form of SLAMF1/CD150 (PubMed:10229804). Interacts with PTPN11 in response to IL-3 (By similarity). Interacts with receptor EPOR (By similarity). Interacts with receptors MS4A2/FCER1B and FCER1G (By similarity). Interacts with receptors FCGR2B and FCGR3 (By similarity). Interacts with receptor FCGR2A, leading to regulate gene expression during the phagocytic process (By similarity). Interacts with GRB2 (PubMed:8723348, PubMed:9108392). Interacts with PLCG1 (By similarity). Interacts with tyrosine kinases SRC and TEC (By similarity). Interacts with c-Met/MET (By similarity). Interacts with MILR1 (tyrosine-phosphorylated) (By similarity). Can weakly interact (via NPXY motif 2) with DAB2 (via PID domain); the interaction is impaired by tyrosine phosphorylation of the NPXY motif (By similarity). Interacts with FCRL3 and FCRL6 (tyrosine phosphorylated form) (PubMed:20933011, PubMed:19843936).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1380477"/>
<interactant intactId="EBI-1580565">
<id>Q9BZW8</id>
<label>CD244</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9092209"/>
<interactant intactId="EBI-3867333">
<id>A8MQ03</id>
<label>CYSRT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1380477"/>
<interactant intactId="EBI-724784">
<id>P31994</id>
<label>FCGR2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1380477"/>
<interactant intactId="EBI-722504">
<id>O75525</id>
<label>KHDRBS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1380477"/>
<interactant intactId="EBI-948001">
<id>Q15323</id>
<label>KRT31</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1380477"/>
<interactant intactId="EBI-10171697">
<id>Q6A162</id>
<label>KRT40</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1380477"/>
<interactant intactId="EBI-10172290">
<id>P60409</id>
<label>KRTAP10-7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1380477"/>
<interactant intactId="EBI-10172052">
<id>P60411</id>
<label>KRTAP10-9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1380477"/>
<interactant intactId="EBI-945833">
<id>Q7Z3S9</id>
<label>NOTCH2NL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1380477"/>
<interactant intactId="EBI-346595">
<id>Q96B97</id>
<label>SH3KBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="6">Cell membrane</location>
<topology evidence="6">Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="6">Membrane raft</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="6">Cytoplasm</location>
<location evidence="6">cytoskeleton</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="8">Membrane</location>
<topology evidence="8">Peripheral membrane protein</topology>
</subcellularLocation>
<text evidence="6">Translocates to the plasma membrane when activated, translocation is probably due to different mechanisms depending on the stimulus and cell type. Translocates from the cytoplasm to membrane ruffles in a FCGR3/CD16-dependent manner. Colocalizes with FC-gamma-RIIB receptor (FCGR2B) or FCGR3/CD16 at membrane ruffles. Tyrosine phosphorylation may also participate in membrane localization.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q92835-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q92835-2</id>
<name>2</name>
<sequence type="described" ref="VSP_027978"/>
</isoform>
<isoform>
<id>Q92835-3</id>
<name>3</name>
<name>SIP-110</name>
<sequence type="described" ref="VSP_027977 VSP_027979"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="16 17 18 19">Specifically expressed in immune and hematopoietic cells. Expressed in bone marrow and blood cells. Levels vary considerably within this compartment. Present in at least 74% of immature CD34+ cells, whereas within the more mature population of CD33+ cells, it is present in only 10% of cells. Present in the majority of T-cells, while it is present in a minority of B-cells (at protein level).</text>
</comment>
<comment type="domain">
<text evidence="4">The SH2 domain interacts with tyrosine phosphorylated forms of proteins such as SHC1 or PTPN11/SHP-2. It competes with that of GRB2 for binding to phosphorylated SHC1 to inhibit the Ras pathway. It is also required for tyrosine phosphorylation (By similarity).</text>
</comment>
<comment type="domain">
<text evidence="4">The NPXY sequence motif found in many tyrosine-phosphorylated proteins is required for the specific binding of the PID domain.</text>
</comment>
<comment type="PTM">
<text evidence="8 19">Tyrosine phosphorylated by the members of the SRC family after exposure to a diverse array of extracellular stimuli such as cytokines, growth factors, antibodies, chemokines, integrin ligands and hypertonic and oxidative stress. Phosphorylated upon IgG receptor FCGR2B-binding.</text>
</comment>
<comment type="similarity">
<text evidence="24">Belongs to the inositol 1,4,5-trisphosphate 5-phosphatase family.</text>
</comment>
<comment type="sequence caution" evidence="24">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAC50454" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<dbReference type="EC" id="3.1.3.86"/>
<dbReference type="EMBL" id="X98429">
<property type="protein sequence ID" value="CAA67071.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U57650">
<property type="protein sequence ID" value="AAB53573.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U50040">
<property type="protein sequence ID" value="AAC50453.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U50041">
<property type="protein sequence ID" value="AAC50454.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U84400">
<property type="protein sequence ID" value="AAB49680.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U53470">
<property type="protein sequence ID" value="AAD00081.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC062985">
<property type="protein sequence ID" value="AAH62985.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC099920">
<property type="protein sequence ID" value="AAH99920.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC113580">
<property type="protein sequence ID" value="AAI13581.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC113582">
<property type="protein sequence ID" value="AAI13583.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS74672.1">
<molecule id="Q92835-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS77543.1">
<molecule id="Q92835-2"/>
</dbReference>
<dbReference type="PIR" id="JC4889">
<property type="entry name" value="JC4889"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001017915.1">
<molecule id="Q92835-1"/>
<property type="nucleotide sequence ID" value="NM_001017915.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005532.2">
<molecule id="Q92835-2"/>
<property type="nucleotide sequence ID" value="NM_005541.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.262886"/>
<dbReference type="UniGene" id="Hs.601911"/>
<dbReference type="PDB" id="2YSX">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-112"/>
</dbReference>
<dbReference type="PDBsum" id="2YSX"/>
<dbReference type="ProteinModelPortal" id="Q92835"/>
<dbReference type="SMR" id="Q92835"/>
<dbReference type="BioGrid" id="109847">
<property type="interactions" value="40"/>
</dbReference>
<dbReference type="ELM" id="Q92835"/>
<dbReference type="IntAct" id="Q92835">
<property type="interactions" value="27"/>
</dbReference>
<dbReference type="MINT" id="MINT-123561"/>
<dbReference type="STRING" id="9606.ENSP00000352575"/>
<dbReference type="ChEMBL" id="CHEMBL1781870"/>
<dbReference type="SwissLipids" id="SLP:000000951"/>
<dbReference type="DEPOD" id="Q92835"/>
<dbReference type="iPTMnet" id="Q92835"/>
<dbReference type="PhosphoSitePlus" id="Q92835"/>
<dbReference type="BioMuta" id="INPP5D"/>
<dbReference type="DMDM" id="158564077"/>
<dbReference type="EPD" id="Q92835"/>
<dbReference type="MaxQB" id="Q92835"/>
<dbReference type="PaxDb" id="Q92835"/>
<dbReference type="PeptideAtlas" id="Q92835"/>
<dbReference type="PRIDE" id="Q92835"/>
<dbReference type="Ensembl" id="ENST00000359570">
<molecule id="Q92835-2"/>
<property type="protein sequence ID" value="ENSP00000352575"/>
<property type="gene ID" value="ENSG00000168918"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000445964">
<molecule id="Q92835-1"/>
<property type="protein sequence ID" value="ENSP00000405338"/>
<property type="gene ID" value="ENSG00000168918"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000629761">
<molecule id="Q92835-2"/>
<property type="protein sequence ID" value="ENSP00000486669"/>
<property type="gene ID" value="ENSG00000281614"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000630854">
<molecule id="Q92835-1"/>
<property type="protein sequence ID" value="ENSP00000487191"/>
<property type="gene ID" value="ENSG00000281614"/>
</dbReference>
<dbReference type="GeneID" id="3635"/>
<dbReference type="KEGG" id="hsa:3635"/>
<dbReference type="UCSC" id="uc032ovq.2">
<molecule id="Q92835-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3635"/>
<dbReference type="DisGeNET" id="3635"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000168918.13"/>
<dbReference type="GeneCards" id="INPP5D"/>
<dbReference type="H-InvDB" id="HIX0057065"/>
<dbReference type="HGNC" id="HGNC:6079">
<property type="gene designation" value="INPP5D"/>
</dbReference>
<dbReference type="HPA" id="CAB016300"/>
<dbReference type="HPA" id="HPA070455"/>
<dbReference type="MIM" id="601582">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q92835"/>
<dbReference type="OpenTargets" id="ENSG00000168918"/>
<dbReference type="PharmGKB" id="PA29887"/>
<dbReference type="eggNOG" id="KOG0565">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5411">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119075"/>
<dbReference type="HOVERGEN" id="HBG106726"/>
<dbReference type="InParanoid" id="Q92835"/>
<dbReference type="KO" id="K03084"/>
<dbReference type="OMA" id="LTKPEMF"/>
<dbReference type="OrthoDB" id="EOG091G00P6"/>
<dbReference type="PhylomeDB" id="Q92835"/>
<dbReference type="TreeFam" id="TF323475"/>
<dbReference type="BioCyc" id="MetaCyc:HS09849-MONOMER"/>
<dbReference type="BRENDA" id="3.1.3.86">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1660499">
<property type="pathway name" value="Synthesis of PIPs at the plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1855204">
<property type="pathway name" value="Synthesis of IP3 and IP4 in the cytosol"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202424">
<property type="pathway name" value="Downstream TCR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-210990">
<property type="pathway name" value="PECAM1 interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912526">
<property type="pathway name" value="Interleukin receptor SHC signaling"/>
</dbReference>
<dbReference type="SignaLink" id="Q92835"/>
<dbReference type="SIGNOR" id="Q92835"/>
<dbReference type="ChiTaRS" id="INPP5D">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q92835"/>
<dbReference type="GeneWiki" id="INPP5D"/>
<dbReference type="GenomeRNAi" id="3635"/>
<dbReference type="PRO" id="PR:Q92835"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000168918"/>
<dbReference type="CleanEx" id="HS_INPP5D"/>
<dbReference type="ExpressionAtlas" id="Q92835">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q92835">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005856">
<property type="term" value="C:cytoskeleton"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0052659">
<property type="term" value="F:inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004445">
<property type="term" value="F:inositol-polyphosphate 5-phosphatase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016314">
<property type="term" value="F:phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034485">
<property type="term" value="F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051425">
<property type="term" value="F:PTB domain binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0017124">
<property type="term" value="F:SH3 domain binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008340">
<property type="term" value="P:determination of adult lifespan"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016064">
<property type="term" value="P:immunoglobulin mediated immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043647">
<property type="term" value="P:inositol phosphate metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050900">
<property type="term" value="P:leukocyte migration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030889">
<property type="term" value="P:negative regulation of B cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045779">
<property type="term" value="P:negative regulation of bone resorption"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050777">
<property type="term" value="P:negative regulation of immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045409">
<property type="term" value="P:negative regulation of interleukin-6 biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045656">
<property type="term" value="P:negative regulation of monocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045659">
<property type="term" value="P:negative regulation of neutrophil differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045671">
<property type="term" value="P:negative regulation of osteoclast differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009968">
<property type="term" value="P:negative regulation of signal transduction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006796">
<property type="term" value="P:phosphate-containing compound metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006661">
<property type="term" value="P:phosphatidylinositol biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046856">
<property type="term" value="P:phosphatidylinositol dephosphorylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045579">
<property type="term" value="P:positive regulation of B cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045648">
<property type="term" value="P:positive regulation of erythrocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.60.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR036691">
<property type="entry name" value="Endo/exonu/phosph_ase_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR005135">
<property type="entry name" value="Endo/exonuclease/phosphatase"/>
</dbReference>
<dbReference type="InterPro" id="IPR000300">
<property type="entry name" value="IPPc"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036860">
<property type="entry name" value="SH2_dom_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF03372">
<property type="entry name" value="Exo_endo_phos"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00401">
<property type="entry name" value="SH2DOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00128">
<property type="entry name" value="IPPc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00252">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56219">
<property type="entry name" value="SSF56219"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<keyword id="KW-0729">SH3-binding</keyword>
<feature type="chain" description="Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1" id="PRO_0000302866">
<location>
<begin position="1"/>
<end position="1189"/>
</location>
</feature>
<feature type="domain" description="SH2" evidence="7">
<location>
<begin position="5"/>
<end position="101"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DAB2" evidence="4">
<location>
<begin position="1016"/>
<end position="1030"/>
</location>
</feature>
<feature type="short sequence motif" description="SH3-binding 1">
<location>
<begin position="124"/>
<end position="129"/>
</location>
</feature>
<feature type="short sequence motif" description="NPXY motif 1">
<location>
<begin position="912"/>
<end position="915"/>
</location>
</feature>
<feature type="short sequence motif" description="SH3-binding 2">
<location>
<begin position="969"/>
<end position="974"/>
</location>
</feature>
<feature type="short sequence motif" description="NPXY motif 2">
<location>
<begin position="1019"/>
<end position="1022"/>
</location>
</feature>
<feature type="short sequence motif" description="SH3-binding 3">
<location>
<begin position="1040"/>
<end position="1051"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="920"/>
<end position="1148"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="243"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="2">
<location>
<position position="915"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="934"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="6">
<location>
<position position="944"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="960"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3">
<location>
<position position="963"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="971"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="6">
<location>
<position position="1022"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_027977" evidence="21">
<location>
<begin position="1"/>
<end position="212"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_027978" evidence="20 22 23">
<location>
<position position="117"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_027979" evidence="21">
<original>TTLLCKELYG</original>
<variation>MFTLSPAPR</variation>
<location>
<begin position="213"/>
<end position="222"/>
</location>
</feature>
<feature type="sequence variant" description="In one patient with acute myeloid leukemya; somatic mutation." id="VAR_034979" evidence="10">
<original>V</original>
<variation>E</variation>
<location>
<position position="685"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9247." id="VAR_059358" evidence="11 16">
<original>H</original>
<variation>Y</variation>
<location>
<position position="1169"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAB49680." ref="4" evidence="24">
<original>DG</original>
<variation>GT</variation>
<location>
<begin position="25"/>
<end position="26"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAB49680." ref="4" evidence="24">
<original>P</original>
<variation>H</variation>
<location>
<position position="1029"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="4"/>
<end position="9"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="12"/>
<end position="22"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="27"/>
<end position="32"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="39"/>
<end position="45"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="50"/>
<end position="57"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="63"/>
<end position="65"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="70"/>
<end position="72"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="76"/>
<end position="78"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="79"/>
<end position="85"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="88"/>
<end position="95"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2YSX"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="15592455"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P97573"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9ES52"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10822173"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12421919"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12529653"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16682172"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19843936"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20933011"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8723348"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8769125"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8874179"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9058707"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9108392"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8723348"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8769125"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8874179"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000305"/>
<sequence length="1189" mass="133292" checksum="7958E91A64A4B68B" modified="2007-09-11" version="2">
MVPCWNHGNITRSKAEELLSRTGKDGSFLVRASESISRAYALCVLYRNCVYTYRILPNED
DKFTVQASEGVSMRFFTKLDQLIEFYKKENMGLVTHLQYPVPLEEEDTGDDPEEDTVESV
VSPPELPPRNIPLTASSCEAKEVPFSNENPRATETSRPSLSETLFQRLQSMDTSGLPEEH
LKAIQDYLSTQLAQDSEFVKTGSSSLPHLKKLTTLLCKELYGEVIRTLPSLESLQRLFDQ
QLSPGLRPRPQVPGEANPINMVSKLSQLTSLLSSIEDKVKALLHEGPESPHRPSLIPPVT
FEVKAESLGIPQKMQLKVDVESGKLIIKKSKDGSEDKFYSHKKILQLIKSQKFLNKLVIL
VETEKEKILRKEYVFADSKKREGFCQLLQQMKNKHSEQPEPDMITIFIGTWNMGNAPPPK
KITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTV
AIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNS
HLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAE
TIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQK
ATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKN
GPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKF
GETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHH
GELTGHFQGEIKLQTSQGKTREKLYDFVKTERDESSGPKTLKSLTSHDPMKQWEVTSRAP
PCSGSSITEIINPNYMGVGPFGPPMPLHVKQTLSPDQQPTAWSYDQPPKDSPLGPCRGES
PPTPPGQPPISPKKFLPSTANRGLPPRTQESRPSDLGKNAGDTLPQEDLPLTKPEMFENP
LYGSLSSFPKPAPRKDQESPKMPRKEPPPCPEPGILSPSIVLTKAQEADRGEGPGKQVPA
PRLRSFTCSSSAEGRAAGGDKSQGKPKTPVSSQAPVPAKRPIKPSRSEINQQTPPTPTPR
PPLPVKSPAVLHLQHSKGRDYRDNTELPHHGKHRPEEGPPGPLGRTAMQ
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>